Tyme Technologies, Inc. (NASDAQ:TYME)
Industry: Healthcare

Tyme Technologies, Inc., a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.

Current Quote*
Last: $0.993
Change: -0.067
Book: $6.842
Volume: 253,266

As Of: 06/14 13:22 ET
*Quotes delayed by 20min.

Graphs for TYME

3 Month Graph

6 Month Graph

1 Year Graph